Proceedings of the National Academy of SciencesBiochemistryPeer-reviewed journal article
Distinct Classes of Gut Bacterial Molybdenum-Dependent Enzymes Produce Urolithins
Minwoo BaeiD, Xueyang DongiD, Julián Ávila-PachecoiD, Quyen D. NguyeniD, Fechi InyamaiD, Vayu Maini RekdaliD, Clary B. ClishiD, Emily P. BalskusiD
- Citations
- 10
- FWCI
- 6.40
- Field percentile
- top 3%
Abstract
Urolithin A is an anti-aging and anti-inflammatory gut bacterial metabolite derived from ellagic acid (EA), a polyphenol abundant in berries and nuts. The conversion of EA to urolithin A involves multiple chemically challenging phenol dehydroxylation steps that produce urolithins with varying bioactivities. Despite their biological and chemical significance, the bacterial enzymes responsible for urolithin production remain unidentified. Here, we use differential gene expression analysis, anaerobic protein expression, and enzyme assays to identify members of two distinct molybdenum enzyme families (the DMSO reductase family and the xanthine oxidase family) capable of regioselective dehydroxylation and urolithin generation. These two enzyme families have distinct substrate requirements, suggesting they employ different catalytic mechanisms for phenol dehydroxylation. Multi-omics analysis of a human cohort uncovers decreased levels of urolithin A and genes encoding urolithin A-producing enzymes in patients with inflammatory bowel disease (IBD), implying reduced health effects of EA consumption in this setting. Together, this study elucidates the molecular basis of urolithin production, expands the known enzymatic repertoire of the human gut microbiome, and suggests a potential link between gut bacterial urolithin production and host inflammation. Significance statementThe human gut microbiome modulates the health effects of dietary compounds by modifying their chemical structures. For example, gut microbes extensively metabolize polyphenols, a group of diverse plant-derived compounds associated with positive health outcomes. Urolithin A, a gut bacterial metabolite derived from a polyphenol abundant in berries and nuts, exhibits potent anti-inflammatory activity. However, the gut bacterial enzymes involved in its production remain largely unknown. Here, we report urolithin-producing gut bacterial enzymes, including four phenol dehydroxylases from two distinct molybdenum-dependent enzyme families. Analyzing human gut microbiomes suggests a potential link between genes encoding these enzymes and host inflammation. Together, our findings fully map urolithin A production to enzymes, increasing our understanding of how the gut microbiome can alter the impacts of diet on human health.
- organism: human
- assay: metagenomics
- research focus: cell type annotation
- research focus: gene regulatory network inference
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The dietary ellagitannin metabolite urolithin A is produced by a molybdenum-dependent dehydroxylase encoded by prevalent human gut Enterocloster spp.
R. Pidgeon, S. Mitchell, … B. Castagner·bioRxiv·Feb 8, 2024
- The presence and induction of regioselective dehydroxylases dictate urolithin metabolism by Enterocloster species
Reilly Pidgeon, Arianna Giurleo, … Bastien Castagner·npj Biofilms and MicrobiomesPeer-reviewed·Nov 26, 2025
- Pyruvate-driven hydrogen production promotes polyphenol bioconversion by gut bacteria
Mohamad Eshaghi Gorji, P. F. Lee, … Danyue Zhao·bioRxiv·Apr 19, 2026
- Discovery of the gut microbial enzyme responsible for bilirubin reduction to urobilinogen
- Identification of the complete pathway for conversion of bilirubin to urobilinogen by human gut bacteria
Baylee J. Russell, Erik Hasenoehrl, … Marco Jost·bioRxiv·Jun 10, 2026
- A widely distributed metalloenzyme class enables gut microbial metabolism of host- and diet-derived catechols
V. Maini Rekdal, P. Nol Bernardino, … E. P. Balskus·bioRxiv·Aug 5, 2019